&Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.1M Buy
22,034
+6,471
+42% +$1.34M 0.02% 592
2026
Q1
$3.28M Buy
15,563
+2,299
+17% +$495K 0.02% 694
2025
Q4
$2.73M Sell
13,264
-208
-2% -$39.1K 0.01% 721
2025
Q3
$2.11M Buy
13,472
+639
+5% +$98.7K 0.01% 726
2025
Q2
$2.16M Buy
12,833
+659
+5% +$97.8K 0.02% 636
2025
Q1
$1.66M Buy
12,174
+4,213
+53% +$537K 0.02% 615
2024
Q4
$951K Buy
7,961
+2,012
+34% +$235K 0.01% 785
2024
Q3
$655K Buy
+5,949
New +$622K 0.01% 743

Other funds holding CAH

&Partners's CAH Position: Q2 2026 in Review

&Partners increased its Cardinal Health (CAH) stake by 42% in Q2 2026, buying an estimated $1.34M and bringing the position to 22,034 shares worth $5.1M. The position accounts for 0.02% of the portfolio, ranked #592.

&Partners first reported a position in CAH in Q3 2024 and has held it in 8 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • &Partners held 22,034 shares of Cardinal Health worth $5.1M as of Q2 2026.
  • &Partners bought 6,471 Cardinal Health shares in Q2 2026, an estimated $1.34M.
  • Cardinal Health made up 0.02% of &Partners's portfolio in Q2 2026, its #592 holding.
  • &Partners first reported a position in Cardinal Health in Q3 2024 and has held it in 8 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.